Abstract 1073: Integrated single cell atlas of human breast cancer enables highly-resolved analysis of tumor heterogeneity and metabolic comorbidities

Abstract Single cell transcriptomics (scRNAseq) remains the method of choice to quantify and annotate cellular heterogeneity in the tumor and its microenvironment (TME), yet most studies are under-powered to associate changes in tumor heterogeneity with phenotypes such as tumor subtype, grade, and patient age, among others. In this study, we created an integrated atlas of human breast cancer (BC), the largest resource of its kind, totaling more than 700, 000 cells across 145 patients, and optimized computational methods to benchmark integration performance, and robustly perform hierarchical cell type annotation. By combining single profiles, a higher-resolution annotation of immune, stromal, and epithelial cell types was achieved. Further, using this integrated atlas, differential abundance analyses identified significant changes in immune and stromal cell type composition associated with tumor grade, subtype, and inferred metabolic comorbidities. For insulin resistance and obesity, we identified significant expansion in exhausted CD4 T Cell populations and interferon signalling in CD8 and macrophage populations. These changes in TME heterogeneity were not discernible or had effects in discordant directions when the analysis was limited to individual BC studies, highlighting the need for atlas-based mega-analysis approaches. This highly-resolved integrated scRNAseq BC atlas represents a valuable resource for hypothesis-driven analyses of tumor heterogeneity. Citation Format: Andrew D. Chen, Christina Ennis, Lina Kroehling, Gerald Denis, Stefano Monti. Integrated single cell atlas of human breast cancer enables highly-resolved analysis of tumor heterogeneity and metabolic comorbidities [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 1073.

Authors

Publication Details

Journal
Cancer Research
Published
2025-04-21
DOI
https://doi.org/10.1158/1538-7445.am2025-1073
Primary Topic
Single-cell and spatial transcriptomics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 1073: Integrated single cell atlas of human breast cancer enables highly-resolved analysis of tumor heterogeneity and metabolic comorbidities

Lina Kroehling, Christina Ennis, Gerald V. Denis, Stefano Monti et al.
Cancer Research
Single-cell and spatial transcriptomics
article

Abstract 1073: Integrated single cell atlas of human breast cancer enables highly-resolved analysis of tumor heterogeneity and metabolic comorbidities

Lina Kroehling, Christina Ennis, Gerald V. Denis, Stefano Monti, Andrew Chen
article en

Abstract

Abstract Single cell transcriptomics (scRNAseq) remains the method of choice to quantify and annotate cellular heterogeneity in the tumor and its microenvironment (TME), yet most studies are under-powered to associate changes in tumor heterogeneity with phenotypes such as tumor subtype, grade, and patient age, among others. In this study, we created an integrated atlas of human breast cancer (BC), the largest resource of its kind, totaling more than 700, 000 cells across 145 patients, and optimized computational methods to benchmark integration performance, and robustly perform hierarchical cell type annotation. By combining single profiles, a higher-resolution annotation of immune, stromal, and epithelial cell types was achieved. Further, using this integrated atlas, differential abundance analyses identified significant changes in immune and stromal cell type composition associated with tumor grade, subtype, and inferred metabolic comorbidities. For insulin resistance and obesity, we identified significant expansion in exhausted CD4 T Cell populations and interferon signalling in CD8 and macrophage populations. These changes in TME heterogeneity were not discernible or had effects in discordant directions when the analysis was limited to individual BC studies, highlighting the need for atlas-based mega-analysis approaches. This highly-resolved integrated scRNAseq BC atlas represents a valuable resource for hypothesis-driven analyses of tumor heterogeneity. Citation Format: Andrew D. Chen, Christina Ennis, Lina Kroehling, Gerald Denis, Stefano Monti. Integrated single cell atlas of human breast cancer enables highly-resolved analysis of tumor heterogeneity and metabolic comorbidities [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 1073.

Cancer ResearchVol. 85(8_Supplement_1)
Openalex Percentile: Top 92%
Single-cell and spatial transcriptomics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.